Fernö M - Search Results

1

Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.

Fernebro E, Dictor M, Bendahl PO, Fernö M, Nilbert M. Fernebro E, et al. Among authors: ferno m. Arch Pathol Lab Med. 2002 Jun;126(6):702-5. doi: 10.5858/2002-126-0702-EOTTMT. Arch Pathol Lab Med. 2002. PMID: 12033959 Free article.

2

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

Nordengren J, Fredstorp Lidebring M, Bendahl PO, Brünner N, Fernö M, Högberg T, Stephens RW, Willén R, Casslén B. Nordengren J, et al. Among authors: ferno m. Int J Cancer. 2002 Jan 20;97(3):379-85. doi: 10.1002/ijc.1611. Int J Cancer. 2002. PMID: 11774293

3

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LV, Klijn JG, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens JA. Look MP, et al. Among authors: ferno m. J Natl Cancer Inst. 2002 Jan 16;94(2):116-28. doi: 10.1093/jnci/94.2.116. J Natl Cancer Inst. 2002. PMID: 11792750 Free article.

4

Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.

Chebil G, Bendahl PO, Fernö M; South Sweden Breast Cancer Group; North Sweden Breast Cancer Group. Chebil G, et al. Among authors: ferno m. Acta Oncol. 2003;42(1):43-7. doi: 10.1080/02841860300672. Acta Oncol. 2003. PMID: 12665330

5

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients.

Look M, van Putten W, Duffy M, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Fred Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder M, Manders P, Edward Fiets W, Blankenstein M, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex L, Klijn J, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens J. Look M, et al. Among authors: ferno m. Thromb Haemost. 2003 Sep;90(3):538-48. doi: 10.1160/TH-02-11-0264. Thromb Haemost. 2003. PMID: 12958624

6

High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer.

Borgfeldt C, Bendahl PO, Gustavsson B, Långström E, Fernö M, Willén R, Grenman S, Casslén B. Borgfeldt C, et al. Among authors: ferno m. Int J Cancer. 2003 Nov 20;107(4):658-65. doi: 10.1002/ijc.11420. Int J Cancer. 2003. PMID: 14520707

7

High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer.

Borgfeldt C, Bendahl PO, Fernö M, Casslén B. Borgfeldt C, et al. Among authors: ferno m. Gynecol Oncol. 2003 Oct;91(1):112-7. doi: 10.1016/s0090-8258(03)00493-1. Gynecol Oncol. 2003. PMID: 14529669

8

Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines.

Baldetorp B, Bendahl PO, Fernö M, Stål O. Baldetorp B, et al. Among authors: ferno m. Cytometry A. 2003 Nov;56(1):1-7. doi: 10.1002/cyto.a.10083. Cytometry A. 2003. PMID: 14566933 Free article.

9

Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.

Chebil G, Bendahl PO, Idvall I, Fernö M. Chebil G, et al. Among authors: ferno m. Acta Oncol. 2003;42(7):719-25. doi: 10.1080/02841860310004724. Acta Oncol. 2003. PMID: 14690157

10

Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck.

Niméus E, Baldetorp B, Bendahl PO, Rennstam K, Wennerberg J, Akervall J, Fernö M. Niméus E, et al. Among authors: ferno m. Oral Oncol. 2004 Jul;40(6):624-9. doi: 10.1016/j.oraloncology.2003.12.014. Oral Oncol. 2004. PMID: 15063391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters